Founded in 2023, the TeamPerMed Center for Personalized Medicine at the University of Tartu and Tartu University Hospital is working to advance personalised medicine and healthcare transformation in Estonia. Our multidisciplinary centre brings together expertise in genomics, bioinformatics, data science, clinical medicine, public health and socio-economic analysis.
In collaboration with University of Helsinki, Erasmus Medical Centre and Erasmus University Rotterdam, we are developing a scalable framework to translate genomic, health, lifestyle and environmental data into personalised medicine tools. These tools aim to support clinical decision-making by guiding prevention and treatment strategies for chronic and hereditary diseases.
TeamPerMed research is focused on applying AI and real-world data from registries, biobanks and electronic health records to identify high-risk individuals early and explore targeted interventions to help prevent or delay disease.
Over the coming years, we will develop clinically relevant tools, including polygenic risk scores, pharmacogenomics applications and clinical decision support systems. These will be validated through (pre)clinical trials, considering the perspectives of clinicians, patients and healthcare systems. Our research also examines the feasibility of integrating these innovations into clinical practice and public health, alongside their socio-economic and long-term health implications.
Advocating for and supporting policy development
around health data in Estonia and Europe
We provide input to healthcare decision makers on matters related to health data as well as the development of infrastructure and legal frameworks concerning patient genetic data. Our aim is to support the Estonian government in the goal of rendering all health data interoperable, while also conducting pilot projects in “data-driven decision-making in medicine and health system”.
Cardiology Program: Piloting Data-Driven Healthcare Tools for Different Target Groups
In close collaboration with cardiologists, we will pilot data-driven healthcare tools in the field of cardiology to create a scalable personalized medicine framework. This initiative combines data science, medical practice, clinical trials, genetics, pharmacogenomics, socio-economic analysis and health policy.
Ophthalmology Program: Testing “scalability” of Personalized Medicine Framework
While working with ophthalmologists on structuring the Estonian ophthalmology data, we will also explore the ease of adapting the learnings from and tools initially developed for cardiology within ophthalmology.
Supporting the Implementation of Pharmacogenetics in Healthcare
We strive to improve healthcare datasets on drug side effects and adherence records, while also advocating for the implementation of pharmacogenetics services for patients in Estonia and elsewhere in Europe.
Creating Specialized Study Programs and Raising Public Awareness
We will develop master’s programs to address critical shortage of workforce in the field of personalized or data-enriched medicine:
– a masters program for genetic counselling
– a masters program in translational medicine,
In addition, we will develop micro-degree programs and other educational formats for professionals as well as awareness raising educational formats for patients and the general population. Our efforts aim to enhance competence and awareness of personalized medicine among healthcare professionals and the general public.